Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,709 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Hematopoietic stem cell transplantation for adults with relapsed acute promyelocytic leukemia in second complete remission.
Sanz J, Labopin M, Sanz MA, Aljurf M, Sousa AB, Craddock C, Zuckerman T, Labussière-Wallet H, Campos A, Grillo G, Ozkurt ZN, Cornelissen JJ, Reményi P, Martino M, Porras RP, Nagler A, Gorin NC, Mohty M; Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT). Sanz J, et al. Among authors: sanz ma. Bone Marrow Transplant. 2021 Jun;56(6):1272-1280. doi: 10.1038/s41409-020-01162-0. Epub 2020 Dec 15. Bone Marrow Transplant. 2021. PMID: 33323947
Morbidity and transplant-related mortality of CBV and BEAM preparative regimens for patients with lymphoid malignancies undergoing autologous stem-cell transplantation.
Puig N, de la Rubia J, Remigia MJ, Jarque I, Martín G, Cupelli L, Sanz GF, Lorenzo I, Sanz J, Martínez JA, Jiménez C, Sanz MA. Puig N, et al. Among authors: sanz ma, sanz j, sanz gf. Leuk Lymphoma. 2006 Aug;47(8):1488-94. doi: 10.1080/10428190500527769. Leuk Lymphoma. 2006. PMID: 16966258 Clinical Trial.
LACE-conditioned autologous stem cell transplantation for relapsed or refractory Hodgkin's lymphoma: treatment outcome and risk factor analysis in 67 patients from a single centre.
Perz JB, Giles C, Szydlo R, O'Shea D, Sanz J, Chaidos A, Wagner S, Davis J, Loaiza S, Marin D, Apperley J, Olavarria E, Rahemtulla A, Lampert I, Naresh K, Samson D, MacDonald D, Kanfer EJ. Perz JB, et al. Among authors: sanz j. Bone Marrow Transplant. 2007 Jan;39(1):41-7. doi: 10.1038/sj.bmt.1705544. Epub 2006 Nov 20. Bone Marrow Transplant. 2007. PMID: 17115062
Characteristics of and risk factors for pneumonia in patients with hematological malignancies developing fever after autologous blood stem cell transplantation.
Puig N, De La Rubia J, Jarque I, Salavert M, Moscardó F, Sanz J, Lorenzo I, Montesinos P, Martín G, Martínez J, Sanz G, Blanes M, Sanz M. Puig N, et al. Among authors: sanz g, sanz j, sanz m. Leuk Lymphoma. 2007 Dec;48(12):2367-74. doi: 10.1080/10428190701694178. Leuk Lymphoma. 2007. PMID: 18067012
Tumor lysis syndrome in patients with acute myeloid leukemia: identification of risk factors and development of a predictive model.
Montesinos P, Lorenzo I, Martín G, Sanz J, Pérez-Sirvent ML, Martínez D, Ortí G, Algarra L, Martínez J, Moscardó F, de la Rubia J, Jarque I, Sanz G, Sanz MA. Montesinos P, et al. Among authors: sanz ma, sanz g, sanz j. Haematologica. 2008 Jan;93(1):67-74. doi: 10.3324/haematol.11575. Haematologica. 2008. PMID: 18166787 Free article.
Analysis of risk factors for outcomes after unrelated cord blood transplantation in adults with lymphoid malignancies: a study by the Eurocord-Netcord and lymphoma working party of the European group for blood and marrow transplantation.
Rodrigues CA, Sanz G, Brunstein CG, Sanz J, Wagner JE, Renaud M, de Lima M, Cairo MS, Fürst S, Rio B, Dalley C, Carreras E, Harousseau JL, Mohty M, Taveira D, Dreger P, Sureda A, Gluckman E, Rocha V. Rodrigues CA, et al. Among authors: sanz g, sanz j. J Clin Oncol. 2009 Jan 10;27(2):256-63. doi: 10.1200/JCO.2007.15.8865. Epub 2008 Dec 8. J Clin Oncol. 2009. PMID: 19064984
Incidence, risk factors, and outcome of cytomegalovirus infection and disease in patients receiving prophylaxis with oral valganciclovir or intravenous ganciclovir after umbilical cord blood transplantation.
Montesinos P, Sanz J, Cantero S, Lorenzo I, Martín G, Saavedra S, Palau J, Romero M, Montava A, Senent L, Martínez J, Jarque I, Salavert M, Córdoba J, Gómez L, Weiss S, Moscardó F, de la Rubia J, Larrea L, Sanz MA, Sanz GF. Montesinos P, et al. Among authors: sanz ma, sanz j, sanz gf. Biol Blood Marrow Transplant. 2009 Jun;15(6):730-40. doi: 10.1016/j.bbmt.2009.03.002. Epub 2009 Apr 11. Biol Blood Marrow Transplant. 2009. PMID: 19450758 Free article. Clinical Trial.
Impact of hematopoietic chimerism at day +14 on engraftment after unrelated donor umbilical cord blood transplantation for hematologic malignancies.
Moscardó F, Sanz J, Senent L, Cantero S, de la Rubia J, Montesinos P, Planelles D, Lorenzo I, Cervera J, Palau J, Sanz MA, Sanz GF. Moscardó F, et al. Among authors: sanz ma, sanz j, sanz gf. Haematologica. 2009 Jun;94(6):827-32. doi: 10.3324/haematol.2008.000935. Haematologica. 2009. PMID: 19483157 Free PMC article.
1,709 results